Larvol Delta - A-Phase-III-Trial-of-ALETA001-for-the-Treatment-of-Participants-With-Bcell-Malignancies

ALETA-001 - Aleta Biotherap

http://clinicaltrials.gov/ct2/show/NCT06045910

Jan 4, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next